Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-04

Clinical Trial Update: Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hypomethylating effects of freeze-dried black raspberries in patients with myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ehab L Atallah | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2022-11-04